Bicara Therapeutics Inc.

BCAX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0002023658

SEC filings (opens in a new tab)

In the last 90 days, Bicara Therapeutics Inc. insiders filed 0 open-market purchases and 7 sales; 171 institutions reported holding it in 13F filings for Q2 2026, worth $2.07B in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Bicara Therapeutics Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025 All holders in Q1 2025

13F holders of BCAX: Q1 2025 compared with Q2 2025
Measure	Q1 2025	Of which not filed for Q2 2025	Q2 2025	Change
Holders	93	1	106	+14
Shares	48.6M	71	51.2M	+2.56M (+5.3%)
Value	$633.9M	$925	$475.3M	−$158.6M (−25.0%)

1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (33)

Institutions that held Bicara Therapeutics Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to BCAX in Q2 2025
Institution	Shares	Value	% of portfolio
Artisan Partners Limited Partnership	402,765	$3.74M	0.01%
Logos Global Management LP	400,000	$3.72M	0.50%
Nan Fung Trinity (HK) Ltd	342,885	$3.19M	0.38%
Readystate Asset Management LP	270,200	$2.51M	0.10%
Citadel Advisors LLC	221,516	$2.06M	0.00%
Point72 Asset Management, L.P.	216,836	$2.01M	0.00%
Sectoral Asset Management Inc	201,395	$1.87M	1.24%
Superstring Capital Management LP	189,699	$1.76M	2.20%
Verition Fund Management LLC	170,962	$1.59M	0.01%
Jain Global LLC	117,910	$1.10M	0.02%
Cubist Systematic Strategies, LLC	102,525	$952.5K	0.01%
Catalio Capital Management, LP	97,800	$908.6K	0.19%
Raymond James Financial Inc	67,701	$628.9K	0.00%
Sphera Funds Management Ltd.	65,679	$610.2K	0.16%
Atom Investors LP	55,141	$512.3K	0.05%
SCS Capital Management LLC	53,430	$496.4K	0.01%
Marshall Wace, LLP	51,809	$481.3K	0.00%
Trexquant Investment LP	50,496	$469.1K	0.01%
Alliancebernstein L.P.	45,560	$423.3K	0.00%
Alps Advisors Inc	29,423	$273.3K	0.00%
Jane Street Group, LLC	28,604	$265.7K	0.00%
Russell Investments Group, Ltd.	27,472	$255.2K	0.00%
Walleye Capital LLC	24,308	$225.8K	0.00%
ADAR1 Capital Management, LLC	22,875	$212.5K	0.03%
Ameriprise Financial Inc	16,090	$149.5K	0.00%
Squarepoint Ops LLC	13,363	$124.1K	0.00%
Mariner, LLC	12,437	$115.5K	0.00%
American Century Companies Inc	11,096	$103.1K	0.00%
Advisor Group Holdings, Inc.	433	$4.02K	0.00%
Versant Capital Management, Inc	95	$883	0.00%
SRS Capital Advisors, Inc.	59	$549	0.00%
Essential Partners LLC	4	$37	0.00%
IFP Advisors, Inc	2	$19	0.00%

Sold out (19)

Institutions that held Bicara Therapeutics Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of BCAX in Q2 2025
Institution	Shares, Q1 2025	Value, Q1 2025
Braidwell LP	2,162,803	$28.2M
Wellington Management Group LLP	1,394,676	$18.2M
Janus Henderson Group PLC	1,343,754	$18.0M
Adage Capital Partners GP, L.L.C.	1,182,900	$15.4M
Baker Bros. Advisors LP	833,333	$10.9M
Fairmount Funds Management LLC	784,170	$10.2M
OrbiMed Advisors LLC	298,301	$3.89M
StemPoint Capital LP	47,078	$613.4K
Jefferies Financial Group Inc.	30,601	$398.7K
Wexford Capital LP	20,000	$260.6K
AQR Capital Management LLC	19,034	$248.0K
Franklin Resources Inc	13,669	$178.1K
MetLife Investment Management	12,163	$158.5K
Corebridge Financial, Inc.	9,456	$123.2K
Nisa Investment Advisors, LLC	163	$2.12K
Simplex Trading, LLC	154	$2.00K
Signaturefd, LLC	80	$1.04K
Rothschild Investment LLC	20	$261
Farther Finance Advisors, LLC	16	$203

Not filed for Q2 2025 yet (1)

Institutions that held Bicara Therapeutics Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding BCAX in Q1 2025 that haven't filed for Q2 2025
Institution	Shares, Q1 2025	Value, Q1 2025
Lindbrook Capital, LLC	71	$925